196 related articles for article (PubMed ID: 24446471)
1. Increased Notch pathway activation in Behçet's disease.
Qi J; Yang Y; Hou S; Qiao Y; Wang Q; Yu H; Zhang Q; Cai T; Kijlstra A; Yang P
Rheumatology (Oxford); 2014 May; 53(5):810-20. PubMed ID: 24446471
[TBL] [Abstract][Full Text] [Related]
2. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behçet's disease.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S56-S63. PubMed ID: 27156371
[TBL] [Abstract][Full Text] [Related]
4. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
5. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease.
Wu L; Wen H; Zhou Y; Yu H; Liu Y; Bai L; Kijlstra A; Yang P
Curr Mol Med; 2014; 14(6):712-22. PubMed ID: 25056541
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of Th17 to Th1 cells in Behçet's disease.
Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
[TBL] [Abstract][Full Text] [Related]
7. Activation of the JAK/STAT pathway in Behcet's disease.
Tulunay A; Dozmorov MG; Ture-Ozdemir F; Yilmaz V; Eksioglu-Demiralp E; Alibaz-Oner F; Ozen G; Wren JD; Saruhan-Direskeneli G; Sawalha AH; Direskeneli H
Genes Immun; 2015 Mar; 16(2):170-5. PubMed ID: 25410656
[TBL] [Abstract][Full Text] [Related]
8. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
9. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
[TBL] [Abstract][Full Text] [Related]
10. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
[TBL] [Abstract][Full Text] [Related]
11. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
12. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
Aktas Cetin E; Cosan F; Cefle A; Deniz G
Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
[TBL] [Abstract][Full Text] [Related]
13. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
[TBL] [Abstract][Full Text] [Related]
14. LPS-induced Src family kinases activity mediates IL-10 production through activation of STAT3 in peripheral blood mononuclear cells of patients with Behçet's Disease.
Irtegun Kandemir S; Tekin MA; Bozkurt M; Dagli AZ; Kalkanli-Tas S
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):116-121. PubMed ID: 29096751
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease.
Tian Y; Wang C; Ye Z; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6434-41. PubMed ID: 22918640
[TBL] [Abstract][Full Text] [Related]
16. Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses.
Ye Z; Deng B; Wang C; Zhang D; Kijlstra A; Yang P
Sci Rep; 2016 Feb; 6():20401. PubMed ID: 26841832
[TBL] [Abstract][Full Text] [Related]
17. Berberine exerts an anti-inflammatory role in ocular Behcet's disease.
Yang Y; Wang Q; Xie M; Liu P; Qi X; Liu X; Li Z
Mol Med Rep; 2017 Jan; 15(1):97-102. PubMed ID: 27922688
[TBL] [Abstract][Full Text] [Related]
18. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells control a T-helper 1 response in patients with Behçet's disease.
Yamaguchi Y; Takahashi H; Satoh T; Okazaki Y; Mizuki N; Takahashi K; Ikezawa Z; Kuwana M
Arthritis Res Ther; 2010; 12(3):R80. PubMed ID: 20459787
[TBL] [Abstract][Full Text] [Related]
20. Engagement of activated Notch signalling in collagen II-specific T helper type 1 (Th1)- and Th17-type expansion involving Notch3 and Delta-like1.
Jiao Z; Wang W; Xu H; Wang S; Guo M; Chen Y; Gao J
Clin Exp Immunol; 2011 Apr; 164(1):66-71. PubMed ID: 21235539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
